Feline Internal Medicine- Feline Arterial Thromboembolism (FATE)
Course Content
The clinical syndrome of feline aortic thromboembolism (FATE) is initiated by the sudden migration of a left atrial thrombus into the systemic arteries. This leads to an acute disorder characterized by signs of ischemia, severe pain, paralysis and eventual rhabdomyolysis in the affected limb(s). The prognosis of FATE is considered poor, with the rate of euthanasia as high as 90% in some reports, often without any attempted treatment. With treatment, the published survival to discharge rates from retrospective studies is between 27% and 45%.
Common underlying causes of FATE are cardiomyopathies, hyperthyroidism, and neoplasia. Possible medical treatments consist of dissolving existing thrombi with fibrinolytic agents or preventing new thrombus formation primarily using antiplatelet drugs and heparin products
- What is the impact of tissue plasminogen activator (TPA) on the treatment of feline aortic thromboembolism (FATE)?
- Should the administration of TPA be advanced as a current standard of care?
- What is a limb score based on physical examination?
- What were the predominant complications described in cats receiving TPA?
- Is intravenous CRI enoxaparin a safe option for the treatment of FATE?
These questions and many more will be answered to the MEAVC Journal club. Join us and be a part of an international vibrant scientific community.
Floris Dröes
Floris Dröes graduated with honors for his DVM from Utrecht University Faculty of Veterinary Medicine (The Netherlands) in 2012. Afterwards he worked in several small animal private practices throughout The Netherlands, and at the emergency service of Utrecht University’s companion animal hospital (NL).
In 2017, he finished a rotating internship at Dick White Referrals (UK), while concurrently attaining a post-graduate certificate in small animal medicine and surgery with distinction from the University of Nottingham (UK).
Summer 2019, Floris joined the Gastrointestinal Laboratory (Texas A&M University, USA) to pursue a PhD in biomedical sciences and small animal veterinary medicine. His PhD research focuses on hemostasis in canine liver diseases. He has special interest in all small animal gastroenterology and ECC (emergency and critical care).
For the future, he would like to expand his knowledge of small animal veterinary medicine by pursuing further clinical training in a residency training program. Besides his research work, Floris currently serves as the secretary/treasurer of the European Society of Comparative Gastroenterology (ESCG).